Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Diversity in GI ‘actually matters and actually saves lives’ Katrina Altersitz; Kate Burba; Monica Stonehill
-
- Leadership: Communicate openly, take the risk, keep your priorities Amy S. Oxentenko, MD, FACP, FACG, AGAF
- Adalimumab may be efficacious, safe treatment for children with ulcerative colitis Julie S. Keenan
- Cholangiopathy after severe COVID-19 may lead to liver injury, failure Monica Stonehill
- Gut microbiota underdeveloped in children with autism spectrum disorder Monica Stonehill
- Low-FODMAP, gluten-free diet improves IBS symptoms Kate Burba
- Macrolides, fluoroquinolones reduce risk for anti-drug antibodies in IBD treatment Kate Burba
- New GI symptoms do not link to increased risk for death in IBD, COVID-19 Kate Burba
- Obesity does not increase risk for serious infection in biologic-treated IBD Kate Burba
-
- Procedure-less intragastric balloon is cost-effective in obesity management Kate Burba
- Switching infliximab biosimilars carries no adverse impact on IBD management Kate Burba
- World Trade Center early responders have increased hepatic steatosis Monica Stonehill
- Cerecor announces positive results for CERC-002 in Crohn’s disease treatment
- ZED1227 prevents increased mucosal injury in celiac disease Kate Burba
- Work together to make diversity in GI the ‘norm’ not an exception Uzma D. Siddiqui, MD, FASGE
- AGA publishes clinical practice update on chemoprevention of colorectal neoplasia Kate Burba
- Q&A: Multitarget FIT bests regular FIT in adenoma detection Kate Burba
-
- VIDEO: ACG looks forward to reconnecting with attendees at annual meeting
- VIDEO: Brain fog, neurocognitive symptoms highly frequent in celiac disease